Rockwell Medical, Inc. to Present at Upcoming September Conferences
August 28 2019 - 4:30PM
Rockwell Medical, Inc. (NASDAQ: RMTI) ("Rockwell Medical" or the
"Company") today announced that Stuart Paul, Chief Executive
Officer, is scheduled to present at two upcoming conferences as
follows:
Conference |
NewsMakers in
the Biotech Industry |
Date: |
Friday, September 6, 2019 |
Time: |
2:10 P.M. Eastern Daylight Time |
Location: |
Millennium Times Square New York, New York, NY |
Webcast: |
http://media.rampard.com/newsmakers/rockwellmedical |
|
|
Conference |
H.C. Wainwright 21st Annual Global Investment Conference |
Date: |
Tuesday, September 10, 2019 |
Time: |
11:40 A.M. Eastern Daylight Time |
Location: |
Lotte New York Palace Hotel, New York, NY |
Webcast: |
http://wsw.com/webcast/hcw5/rmti/ |
The presentations will be webcast live at the aforementioned
time, and archived for 30 days thereafter, via the Company’s
website at www.rockwellmed.com, under the “Investors” section.
To schedule a one-on-one meeting with management, please contact
your H.C. Wainwright and/or NewsMakers representatives, or Lisa
Wilson at lwilson@insitecony.com.
About Rockwell Medical Rockwell Medical is a
biopharmaceutical company dedicated to improving outcomes for
patients with anemia, with an initial focus on end-stage renal
disease (ESRD) and chronic kidney disease (CKD). Rockwell Medical's
exclusive renal drug therapy, Triferic, supports disease management
initiatives to improve the quality of life and care of dialysis
patients and is intended to deliver safe and effective therapy,
while decreasing drug administration costs and improving patient
convenience. The Company has developed multiple formulations of
Triferic: (1) Dialysate Triferic; and (2) I.V. Triferic. Dialysate
Triferic is the only FDA-approved therapeutic indicated for iron
replacement and maintenance of hemoglobin in hemodialysis patients.
The Company’s strategy is to bring its therapeutics to market in
the United States and to utilize partners to develop and
commercialize such therapeutics in international markets. Rockwell
Medical is also an established manufacturer, supplier and leader in
delivering high-quality hemodialysis concentrates/dialysates to
dialysis providers and distributors in the U.S. and abroad. Please
visit www.rockwellmed.com for more information.
Investor Relations:Lisa M. WilsonIn-Site
Communications, Inc.T: 212-452-2793E: lwilson@insitecony.com
Rockwell Medical (NASDAQ:RMTI)
Historical Stock Chart
From Mar 2024 to Apr 2024
Rockwell Medical (NASDAQ:RMTI)
Historical Stock Chart
From Apr 2023 to Apr 2024